Real-time enrollment status for this functional hypothalamic amenorrhea (fha) clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 4:08 PM UTC
| NCT Number | NCT07235917 |
| Recruiting Status | Recruiting |
| Condition | Functional Hypothalamic Amenorrhea (FHA) |
| Phase | PHASE2 |
| Target Enrollment | 34 participants |
| Active Locations | 11 sites in the US |
| Sponsor | Regeneron Pharmaceuticals |
| Last Updated on CT.gov | October 1, 2026 (1 week ago) |
As of October 12, 2026: Clinical trial NCT07235917 is currently recruiting participants. This phase2 study for functional hypothalamic amenorrhea (fha) is actively seeking new participants at 11 locations across the United States. The study is sponsored by Regeneron Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07235917 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 11 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07235917 was last updated 1 week ago (October 1, 2026). HelloStudys verifies this status automatically.